PDGFRA and atrial fibrillation: In contrast, PDGFRα+ALCAM−/lowNG2+ cells, here referred to as PFs, did not exhibit a characteristic AF profile (Peixoto et al., 2022), they were barely detectable at E12.5 and increased in frequency as development progressed (Fig. 1 C and Fig. S1 D).